ReviewDisease markers2020

Explicating the Pivotal Pathogenic, Diagnostic, and Therapeutic Biomarker Potentials of Myeloid-Derived Suppressor Cells in Glioblastoma.

Seidu A RichardPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.